1 |
ClinicalTrials.gov (NCT03327727) VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults. U.S. National Institutes of Health.
|
2 |
Functional selection of protease inhibitory antibodies.Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16314-16319. doi: 10.1073/pnas.1903330116. Epub 2019 Jul 30.
|
3 |
Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages.J Immunol. 2004 Nov 1;173(9):5635-43. doi: 10.4049/jimmunol.173.9.5635.
|
4 |
Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.Front Immunol. 2019 May 7;10:890. doi: 10.3389/fimmu.2019.00890. eCollection 2019.
|
5 |
PTX3 binds MD-2 and promotes TRIF-dependent immune protection in aspergillosis.J Immunol. 2014 Sep 1;193(5):2340-8. doi: 10.4049/jimmunol.1400814. Epub 2014 Jul 21.
|
6 |
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity.Blood. 2010 Dec 9;116(24):5394-402. doi: 10.1182/blood-2010-04-279307. Epub 2010 Aug 31.
|
7 |
Overexpression of Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin in Dendritic Cells Protecting against Aspergillosis.Chin Med J (Engl). 2018 Nov 5;131(21):2575-2582. doi: 10.4103/0366-6999.244103.
|
8 |
Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis.Clin Microbiol Infect. 2019 Apr;25(4):504-510. doi: 10.1016/j.cmi.2018.06.015. Epub 2018 Jun 28.
|
|
|
|
|
|
|